Textron
TXT
73.03
-2.50
-3.31%
Textron
US · TXT
#1236 by market cap
Listed 1970
73.03
-2.50
-3.31%
Live - 5344 symbols - heartbeat 126s ago
· 2026-10-08 07:40
Pre-market
73.03
0.00%
After-hours
73.50
+0.64%
Overnight
73.03
0.00%
- Market cap
- 12.56B
- P/E (TTM)i
- 13.78
- P/Bi
- 1.56
- EPSi
- 5.11
- Div yieldi
- 0.11%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on TXT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.46, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.01% YoY
Margins
- Gross margin
- 18.21%
- Operating margin
- 6.76%
- Net margin
- 6.22%
Key ratios & quality
- Enterprise valuei
- 14.41B
- PEG ratioi
- 6.07
- Altman Z-Scorei
- 2.46
PEG uses trailing P/E against the 3-year net income growth rate (2.27%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.97B | 13.63B | 11.65B | 12.38B | 12.87B | 13.68B | 13.70B | 14.80B |
| Gross profit | 2.38B | 2.22B | 1.56B | 2.09B | 2.67B | 2.85B | 2.50B | 2.70B |
| Selling & admin expenses | 1.28B | 1.15B | 1.05B | 1.22B | 1.19B | 1.23B | 1.16B | 1.17B |
| Research & development | -- | -- | -- | -- | 601.00M | 570.00M | 491.00M | 521.00M |
| Operating profit | 1.10B | 1.07B | 512.00M | 864.00M | 883.00M | 1.05B | 855.00M | 1.00B |
| Pretax profit | 1.38B | 942.00M | 282.00M | 873.00M | 1.02B | 1.09B | 943.00M | 1.14B |
| Tax | 162.00M | 127.00M | -27.00M | 126.00M | 154.00M | 165.00M | 118.00M | 214.00M |
| Net profit | 1.22B | 815.00M | 309.00M | 746.00M | 861.00M | 921.00M | 824.00M | 921.00M |
| Basic EPS | 5 | 4 | 1 | 3 | 4 | 5 | 4 | 5 |
| Diluted EPS | 4.83 | 3.50 | 1.35 | 3.30 | 4.01 | 4.56 | 4.33 | 5.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 3.31B | 3.72B | 3.60B | 4.18B | 3.70B | 3.83B |
| Gross profit | 634.00M | 709.00M | 654.00M | 698.00M | 672.00M | 694.00M |
| Selling & admin expenses | 298.00M | 303.00M | 257.00M | 315.00M | 321.00M | 311.00M |
| Research & development | 132.00M | 137.00M | 118.00M | 134.00M | 120.00M | 116.00M |
| Operating profit | 204.00M | 269.00M | 279.00M | 249.00M | 231.00M | 267.00M |
| Pretax profit | 241.00M | 301.00M | 316.00M | 279.00M | 267.00M | 304.00M |
| Tax | 34.00M | 56.00M | 81.00M | 43.00M | 47.00M | 56.00M |
| Net profit | 207.00M | 245.00M | 234.00M | 235.00M | 220.00M | 248.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 1.13 | 1.35 | 1.31 | 1.33 | 1.25 | 1.42 |
Balance sheet
| Line item | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.49B | 7.92B | 8.25B | 8.05B | 8.04B | 8.41B | 7.75B | 8.57B |
| Cash & ST investments | 1.11B | 1.36B | 2.25B | 2.12B | 2.04B | 2.18B | 1.44B | 2.03B |
| Inventory | 3.82B | 4.07B | 3.51B | 3.47B | 3.55B | 3.91B | 4.07B | 4.28B |
| Total assets | 14.26B | 15.02B | 15.44B | 15.83B | 16.29B | 16.86B | 16.84B | 18.13B |
| Total current liabilities | 3.51B | 3.85B | 3.27B | 3.14B | 3.67B | 4.38B | 4.39B | 4.35B |
| Short-term debt | 258.00M | 561.00M | 509.00M | 6.00M | 7.00M | 357.00M | 357.00M | 5.00M |
| Long-term debt | 3.53B | 3.25B | 3.86B | 3.76B | 3.55B | 3.52B | 3.23B | 3.87B |
| Total liabilities | 9,072,000,000.00 | 9,500,000,000.00 | 9,598,000,000.00 | 9,012,000,000.00 | 9,180,000,000.00 | 9,869,000,000.00 | 9,634,000,000.00 | 10,254,000,000.00 |
| Total equity | 5.19B | 5.52B | 5.85B | 6.82B | 7.11B | 6.99B | 7.20B | 7.88B |
| Retained earnings | 5.41B | 5.68B | 5.97B | 5.87B | 5.90B | 5.86B | 5.61B | 5.78B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 7.89B | 8.01B | 8.41B | 8.57B | 8.64B | 8.68B |
| Cash & ST investments | 1.25B | 1.43B | 1.52B | 2.03B | 1.61B | 1.61B |
| Inventory | 4.27B | 4.34B | 4.46B | 4.28B | 4.56B | 4.72B |
| Total assets | 16.94B | 17.08B | 17.38B | 18.13B | 18.14B | 18.13B |
| Total current liabilities | 4.39B | 4.36B | 4.58B | 4.35B | 4.69B | 4.66B |
| Short-term debt | 356.00M | 356.00M | 356.00M | 5.00M | 355.00M | 355.00M |
| Long-term debt | 3.38B | 3.38B | 3.38B | 3.87B | 3.45B | 3.45B |
| Total liabilities | 9,667,000,000.00 | 9,643,000,000.00 | 9,888,000,000.00 | 10,254,000,000.00 | 10,139,000,000.00 | 10,080,000,000.00 |
| Total equity | 7.28B | 7.43B | 7.49B | 7.88B | 8.00B | 8.05B |
| Retained earnings | 5.81B | 6.05B | 6.28B | 5.78B | 6.00B | 6.25B |
Cash flow
| Line item | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.11B | 1.01B | 768.00M | 1.60B | 1.49B | 1.27B | 1.01B | 1.31B |
| Depreciation & amortization | 437.00M | 416.00M | 391.00M | 390.00M | 397.00M | 395.00M | 382.00M | 401.00M |
| Free cash flow | 738.00M | 675.00M | 451.00M | 1.22B | 1.13B | 864.00M | 650.00M | 929.00M |
| Dividends paid | -20.00M | -18.00M | -18.00M | -18.00M | -17.00M | -16.00M | -12.00M | -18.00M |
| Stock buybacks / issuance | -1.78B | -503.00M | -183.00M | -921.00M | -867.00M | -1.17B | -1.12B | -822.00M |
| Ending cash balance | 1.11B | 1.36B | 2.25B | 2.12B | 2.04B | 2.18B | 1.44B | 2.03B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -124.00M | 387.00M | 349.00M | 700.00M | -117.00M | 304.00M |
| Depreciation & amortization | 92.00M | 100.00M | 97.00M | 112.00M | 96.00M | 94.00M |
| Free cash flow | -180.00M | 309.00M | 273.00M | 527.00M | -250.00M | 209.00M |
| Dividends paid | -3.00M | -4.00M | -4.00M | -7.00M | -3.00M | -4.00M |
| Stock buybacks / issuance | -215.00M | -214.00M | -206.00M | -187.00M | -168.00M | -209.00M |
| Ending cash balance | 1.25B | 1.43B | 1.52B | 2.03B | 1.61B | 1.61B |
Returns & efficiency
| Line item | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.55 | 15.22 | 5.44 | 11.79 | 12.36 | 13.06 | 11.61 | 12.22 |
| ROA %i | 8.26 | 5.57 | 2.03 | 4.77 | 5.36 | 5.56 | 4.89 | 5.27 |
| ROIC %i | 14.77 | 10.52 | 4.40 | 8.34 | 8.96 | 9.16 | 8.39 | 9.08 |
| 5-year avg ROE %i | 15.05 | 15.32 | 13.39 | 12.09 | 13.47 | 11.57 | 10.85 | 12.21 |
| EBIT margin %i | 11.09 | 8.17 | 3.85 | 8.20 | 8.73 | 8.51 | 7.59 | 8.53 |
| FCF / sales %i | 5.28 | 4.95 | 3.87 | 9.88 | 8.81 | 6.31 | 4.74 | 6.28 |
| Current ratioi | 2.14 | 2.06 | 2.52 | 2.57 | 2.19 | 1.92 | 1.76 | 1.97 |
| Quick ratioi | 0.82 | 0.77 | 1.16 | 1.14 | 0.94 | 0.83 | 0.68 | 0.79 |
| Debt / assetsi | 26.53 | 25.37 | 28.29 | 23.80 | 21.83 | 22.98 | 21.31 | 21.39 |
| LT debt / equityi | 67.91 | 58.88 | 66.04 | 55.19 | 49.91 | 50.34 | 44.85 | 49.18 |
| Interest coveragei | 9.34 | 6.51 | 2.70 | 7.15 | 10.50 | 15.12 | 10.72 | 10.02 |
| Revenue CAGR (3Y) %i | 1.35 | -0.38 | -6.38 | -3.95 | -1.90 | 5.50 | 3.43 | 4.77 |
| Net income CAGR (3Y) %i | 20.58 | -5.38 | 0.22 | -15.17 | 1.85 | 43.91 | 3.37 | 2.27 |
| FCF CAGR (3Y) %i | 3.27 | 12.11 | -4.20 | 18.34 | 18.88 | 24.20 | -19.00 | -6.43 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 11.69 | 11.42 | 11.45 | 12.22 | 12.23 | 12.10 |
| ROA %i | 4.98 | 4.87 | 4.89 | 5.27 | 5.32 | 5.32 |
| ROIC %i | 8.60 | 8.47 | 8.49 | 9.08 | 9.11 | 9.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.59 | 7.37 | 7.76 | 8.53 | 8.52 | 8.49 |
| FCF / sales %i | 3.91 | 3.98 | 4.88 | 6.28 | 5.66 | 4.96 |
| Current ratioi | 1.80 | 1.84 | 1.84 | 1.97 | 1.84 | 1.86 |
| Quick ratioi | 0.64 | 0.66 | 0.69 | 0.79 | 0.66 | 0.65 |
| Debt / assetsi | 22.04 | 21.87 | 21.48 | 21.39 | 20.97 | 20.98 |
| LT debt / equityi | 46.43 | 45.45 | 45.08 | 49.18 | 43.11 | 42.84 |
| Interest coveragei | 9.93 | 9.26 | 9.53 | 10.02 | 9.88 | 9.77 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Textron Aviation is the largest reported line at 40.34% of revenue, across 5 reported segments.
- No single line clears half of revenue; BELL is next at 28.06%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Textron Aviation40.34%
BELL28.06%
industrial22.16%
Textron Systems9.07%
Finance0.37%
Quote time 2026-10-08 07:40:23 · For reference only, not investment advice and not tailored to your situation.